1. Home
  2. AKBA vs STRT Comparison

AKBA vs STRT Comparison

Compare AKBA & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.39

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

N/A

Current Price

$59.11

Market Cap

241.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
AKBA
STRT
Founded
2007
1908
Country
United States
United States
Employees
194
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
107.0M
241.4M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
AKBA
STRT
Price
$0.39
$59.11
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$2.67
★ $82.00
AVG Volume (30 Days)
★ 7.4M
46.6K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 93.94
9.17
EPS
N/A
★ 1.19
Revenue
N/A
★ $439,195,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.46
P/E Ratio
★ N/A
$52.27
Revenue Growth
N/A
★ 5.24
52 Week Low
$0.36
$57.01
52 Week High
$1.73
$93.00

Technical Indicators

Market Signals
Indicator
AKBA
STRT
Relative Strength Index (RSI) 33.07 36.34
Support Level $0.36 $57.01
Resistance Level $1.00 $84.30
Average True Range (ATR) 0.07 2.25
MACD -0.01 -0.01
Stochastic Oscillator 6.68 6.67

Price Performance

Historical Comparison
AKBA
STRT

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs automotive access company that designs and delivers safe, secure, and engineered access solutions for the automotive and mobility markets. Built on generations of access and security engineering expertise, partner closely with OEMs to create differentiated, system level access experiences for end consumers. Its product portfolio spans the access journey from Permission, enabling secure vehicle entry through advanced mechanical and electronic systems; to Motion, delivering effortless, reliable powered access that enhances everyday usability; and through to Hold, providing precision engineered latching solutions.

Share on Social Networks: